PHARMACOKINETICS OF 2-METHYL-9-HYDROXYELLIPTICINIUM ACETATE (NSC-264137) IN CANCER-PATIENTS - PHASE-I STUDY

被引：20

作者：

GOUYETTE, A

HUERTAS, D

DROZ, JP

ROUESSE, J

AMIEL, JL

机构：

[1] INST GUSTAVE ROUSSY,DEPT STAT,F-94800 VILLEJUIF,FRANCE

[2] INST GUSTAVE ROUSSY,DEPT MED ADULTE,F-94800 VILLEJUIF,FRANCE

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1982年 / 18卷 / 12期

关键词：

D O I：

10.1016/0277-5379(82)90130-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1285 / 1292

页数：8

共 19 条

[11] PRELIMINARY TRIAL OF 9-HYDROXY-2-METHYL ELLIPTICINIUM (NSC 264-137) IN ADVANCED HUMAN CANCERS [J].

JURET, P ;

TANGUY, A ;

GIRARD, A ;

LETALAER, JY ;

ABBATUCCI, JS ;

DATXUONG, N ;

LEPECQ, JB ;

PAOLETTI, C .

EUROPEAN JOURNAL OF CANCER, 1978, 14 (02) :205-206

[12]

JURET P, 1979, NOUV PRESSE MED, V8, P1495

[13]

LEPECQ JB, 1975, CR ACAD SCI D NAT, V281, P1365

[14] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC SEPARATION AND TRACE DETERMINATION OF THE ANTI-TUMOR DERIVATIVES OF ELLIPTICINE AND RELATED QUATERNARY AMMONIUM-COMPOUNDS [J].

MUZARD, G ;

LEPECQ, JB .

JOURNAL OF CHROMATOGRAPHY, 1979, 169 (FEB) :446-452

[15]

PAOLETTI C, 1980, RECENT RESULTS CANC, V74, P107

[16] SYMBOLS IN PHARMACOKINETICS [J].

ROWLAND, M ;

TUCKER, G .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (05) :497-507

[17]

SCHOLTAN W, 1935, ARZNEIM FORSCH, V108, P285

[18]

VANBAC N, 1980, CANCER TREAT REP, V64, P879

[19]

VANBAC N, 1975, J LABELLED COMPD RAD, V11, P241

← 1 2 →